CHICAGO, Sept. 30 /PRNewswire/ -- The non-profit International Serious Adverse Events Consortium (iSAEC) announced today the launch of the second stage of its landmark effort to research the genetic underpinnings of drug-induced serious adverse events (SAEs).

SILVER SPRING, Md., July 8 /PRNewswire-USNewswire/ -- The U.S.

Serious side effects reported when used to treat or prevent night time leg cramps SILVER SPRING, Md., July 8 /PRNewswire-USNewswire/ -- The U.S.

Data focus on genetic basis of drug-induced liver injury and serious skin reaction SILVER SPRING, Md., Feb. 19 /PRNewswire-USNewswire/ -- The U.S.

SILVER SPRING, Md., Sept. 22 /PRNewswire-USNewswire/ -- The U.S.